Frontiers in Aging Neuroscience | Parkinson’s Disease and Aging-related Movement Disorders

Original Research

Published on 27 Mar 2024

Two-sample Mendelian randomization analysis of 91 circulating inflammatory protein levels and amyotrophic lateral sclerosis

in Parkinson’s Disease and Aging-related Movement Disorders

Chenxu Xiao
Xiaochu Gu
Yu Feng
Jing Shen

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2024.1367106

4,564 views
4 citations

Original Research

Published on 22 Mar 2024

Causal role of immune cells on risk of Parkinson’s disease: a Mendelian randomization study

in Parkinson’s Disease and Aging-related Movement Disorders

Jian Gu
Yue Qiao
Shuyan Cong

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2024.1368374

3,835 views
6 citations

Original Research

Published on 20 Mar 2024

Reduced maximal range of ocular movements and its response to acute levodopa challenge in Parkinson's disease

in Parkinson’s Disease and Aging-related Movement Disorders

Juan Li
Yuewen Li
Xianzhou Chu
Mengxue Jiang
Tieyu Wu
Xianwen Chen

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2024.1368539

2,205 views

Original Research

Published on 15 Mar 2024

MRI brain structural and functional networks changes in Parkinson disease with REM sleep behavior disorders

in Parkinson’s Disease and Aging-related Movement Disorders

Fang Wang
Zhigang Zhu
Chuanbin Zhou
Yongyun Zhu
Yangfan Zhu
Chunyu Liang
Jieyu Chen
Bin Liu
Hui Ren
Xinglong Yang

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2024.1364727

2,876 views
2 citations

Original Research

Published on 12 Mar 2024

Analyzing changes in parkinsonian speech over time: a diachronic experimental phonetics study

in Parkinson’s Disease and Aging-related Movement Disorders

Massimo Pettorino
Marta Maffia

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2024.1334198

3,003 views

Original Research

Published on 08 Mar 2024

Exploring the application and challenges of fNIRS technology in early detection of Parkinson’s disease

in Parkinson’s Disease and Aging-related Movement Disorders

Pengsheng Hui
Yu Jiang
Jie Wang
Congxiao Wang
Yingqi Li
Boyan Fang
Hujun Wang
Yingpeng Wang
Shuyan Qie

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2024.1354147

4,323 views
2 citations

Original Research

Published on 04 Mar 2024

Impact of olfactory function on the trajectory of cognition, motor function, and quality of life in Parkinson’s disease

in Parkinson’s Disease and Aging-related Movement Disorders

Chia-Yen Lin
Yu-Shan Tsai
Ming-Hong Chang

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2024.1329551

1,729 views
2 citations

Original Research

Published on 04 Mar 2024

Short term effects of contralateral tendon vibration on motor unit discharge rate variability and force steadiness in people with Parkinson’s disease

in Parkinson’s Disease and Aging-related Movement Disorders

Changki Kim
Daryl J. Wile
Sarah N. Kraeutner
Kaylee A. Larocque
Jennifer M. Jakobi

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2024.1301012

1,661 views
1 citation

Original Research

Published on 22 Feb 2024

Association of immune cell traits with Parkinson’s disease: a Mendelian randomization study

in Parkinson’s Disease and Aging-related Movement Disorders

Zhiwei Song
Wangyu Li
Yupeng Han
Yiya Xu
Haiqi Ding
Yinzhou Wang

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2024.1340110

4,501 views
5 citations

Original Research

Published on 22 Feb 2024

Associative role of HLA-DRB1 as a protective factor for susceptibility and progression of Parkinson’s disease: a Chinese cross-sectional and longitudinal study

in Parkinson’s Disease and Aging-related Movement Disorders

Raoli He
Yuqi Zeng
Chaodong Wang
Lina Chen
Guoen Cai
Ying Chen
Yingqing Wang
Qinyong Ye
Xiaochun Chen

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2024.1361492

3,178 views

Hypothesis and Theory

Published on 21 Feb 2024

Metabolic energy decline coupled dysregulation of catecholamine metabolism in physiologically highly active neurons: implications for selective neuronal death in Parkinson’s disease

in Parkinson’s Disease and Aging-related Movement Disorders

Kandatege Wimalasena
Oluwatosin Adetuyi
Maya Eldani

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2024.1339295

2,190 views
2 citations

Original Research

Published on 15 Feb 2024

High-frequency multimodal training with a focus on Tai Chi in people with Parkinson’s disease: a pilot study

in Parkinson’s Disease and Aging-related Movement Disorders

Ketevan Toloraia
Ute Gschwandtner
Peter Fuhr

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2024.1335951

2,850 views
2 citations

Study Protocol

Published on 14 Feb 2024

Protocol for a randomized, placebo-controlled, double-blind phase IIa study of the safety, tolerability, and symptomatic efficacy of the ROCK-inhibitor Fasudil in patients with Parkinson’s disease (ROCK-PD)

in Parkinson’s Disease and Aging-related Movement Disorders

Andreas W. Wolff
Helen Bidner
Yvonne Remane
Janine Zimmer
Dag Aarsland
Olivier Rascol
Richard K. Wyse
Alexander Hapfelmeier
Paul Lingor

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2024.1308577

3,706 views
6 citations

Review

Published on 13 Feb 2024

The contribution of preclinical magnetic resonance imaging and spectroscopy to Huntington’s disease

in Parkinson’s Disease and Aging-related Movement Disorders

Jean-Baptiste Pérot
Emmanuel Brouillet
Julien Flament

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2024.1306312

3,915 views
2 citations

Original Research

Published on 07 Feb 2024

Assessment of acetylcholinesterase activity in CD9-positive exosomes from patients with Parkinson’s disease

in Parkinson’s Disease and Aging-related Movement Disorders

Sumin Jeong
Kyu Hwan Shim
Danyeong Kim
Heewon Bae
Da-Eun Jeong
Min Ju Kang
Seong Soo A. An

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2024.1332455

1,864 views
1 citation

Original Research

Published on 07 Feb 2024

Effects of non-invasive vagus nerve stimulation on clinical symptoms and molecular biomarkers in Parkinson’s disease

in Parkinson’s Disease and Aging-related Movement Disorders

Banashree Mondal
Supriyo Choudhury
Rebecca Banerjee
Akash Roy
Koustav Chatterjee
Purba Basu
Ravi Singh
Saptak Halder
Shantanu Shubham
Stuart N. Baker

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1331575

4,432 views
4 citations

Navigation group

Articles

Two-sample Mendelian randomization analysis of 91 circulating inflammatory protein levels and amyotrophic lateral sclerosis

Causal role of immune cells on risk of Parkinson’s disease: a Mendelian randomization study

Reduced maximal range of ocular movements and its response to acute levodopa challenge in Parkinson's disease

MRI brain structural and functional networks changes in Parkinson disease with REM sleep behavior disorders

Analyzing changes in parkinsonian speech over time: a diachronic experimental phonetics study

Exploring the application and challenges of fNIRS technology in early detection of Parkinson’s disease

Impact of olfactory function on the trajectory of cognition, motor function, and quality of life in Parkinson’s disease

Short term effects of contralateral tendon vibration on motor unit discharge rate variability and force steadiness in people with Parkinson’s disease

Association of immune cell traits with Parkinson’s disease: a Mendelian randomization study

Associative role of HLA-DRB1 as a protective factor for susceptibility and progression of Parkinson’s disease: a Chinese cross-sectional and longitudinal study

Metabolic energy decline coupled dysregulation of catecholamine metabolism in physiologically highly active neurons: implications for selective neuronal death in Parkinson’s disease

High-frequency multimodal training with a focus on Tai Chi in people with Parkinson’s disease: a pilot study

Protocol for a randomized, placebo-controlled, double-blind phase IIa study of the safety, tolerability, and symptomatic efficacy of the ROCK-inhibitor Fasudil in patients with Parkinson’s disease (ROCK-PD)

The contribution of preclinical magnetic resonance imaging and spectroscopy to Huntington’s disease

Assessment of acetylcholinesterase activity in CD9-positive exosomes from patients with Parkinson’s disease

Effects of non-invasive vagus nerve stimulation on clinical symptoms and molecular biomarkers in Parkinson’s disease